NYSE:HUM - Humana Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $439.32
  • Forecasted Upside: -1.12 %
  • Number of Analysts: 21
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 15 Buy Ratings
  • 0 Strong Buy Ratings
$444.31
▲ +3.15 (0.71%)
1 month | 3 months | 12 months
Get New Humana Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HUM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HUM

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$439.32
▼ -1.12% Downside Potential
This price target is based on 21 analysts offering 12 month price targets for Humana in the last 3 months. The average price target is $439.32, with a high forecast of $510.00 and a low forecast of $358.00. The average price target represents a -1.12% upside from the last price of $444.31.
Buy
The current consensus among 21 contributing investment analysts is to buy stock in Humana.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
5/3/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
8/1/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 6 hold ratings
  • 0 sell ratings
10/30/2019
  • 0 strong buy ratings
  • 12 buy ratings
  • 4 hold ratings
  • 0 sell ratings
1/28/2020
  • 0 strong buy ratings
  • 12 buy ratings
  • 5 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 14 buy ratings
  • 6 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 6 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 15 buy ratings
  • 6 hold ratings
  • 0 sell ratings
10/24/2020

Latest Recommendations

  • 0 strong buy ratings
  • 15 buy ratings
  • 6 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/13/2020TruistBoost Price Target$455.00 ➝ $475.00Low
i
10/1/2020Sanford C. BernsteinInitiated CoverageMarket Perform$459.00Medium
i
10/1/2020Piper SandlerBoost Price TargetOverweight$473.00 ➝ $495.00Low
i
9/10/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$397.00 ➝ $431.00High
i
8/18/2020JPMorgan Chase & Co.Boost Price TargetOverweight$394.00 ➝ $452.00Low
i
8/17/2020Royal Bank of CanadaBoost Price TargetSector Perform$388.00 ➝ $420.00Low
i
8/10/2020StephensBoost Price TargetOverweight$433.00 ➝ $450.00Low
i
8/7/2020MizuhoBoost Price TargetBuy$420.00 ➝ $462.00High
i
Rating by Ann Hynes at Mizuho
8/6/2020Credit Suisse GroupReiterated RatingBuyLow
i
8/6/2020Piper SandlerBoost Price TargetOverweight$442.00 ➝ $473.00Medium
i
8/6/2020OppenheimerBoost Price TargetOutperform$425.00 ➝ $440.00Low
i
8/6/2020SVB LeerinkBoost Price TargetOutperform$465.00 ➝ $496.00Medium
i
Rating by D. Ha at SVB Leerink LLC
7/1/2020SVB LeerinkInitiated CoverageOutperform$465.00Low
i
Rating by S. Davis at SVB Leerink LLC
6/18/2020Deutsche Bank AktiengesellschaftLower Price TargetHold$421.00 ➝ $397.00Low
i
6/17/2020Cantor FitzgeraldBoost Price Target$405.00 ➝ $410.00Medium
i
6/16/2020CowenReiterated RatingOutperform ➝ Market Perform$410.00Medium
i
6/5/2020Goldman Sachs GroupInitiated CoverageBuy$510.00Medium
i
Rating by Stephen Tanal at Goldman Sachs Group Inc
5/21/2020SunTrust BanksBoost Price TargetHold$400.00 ➝ $440.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
5/4/2020MizuhoBoost Price TargetBuy$405.00 ➝ $420.00Low
i
Rating by Ann Hynes at Mizuho
4/30/2020CSFBBoost Price TargetOutperform$400.00 ➝ $423.00Medium
i
4/30/2020Credit Suisse GroupBoost Price TargetOutperform$400.00 ➝ $423.00High
i
4/30/2020CitigroupBoost Price TargetBuy$424.00 ➝ $435.00Medium
i
4/30/2020Morgan StanleyBoost Price TargetOverweight$375.00 ➝ $500.00Medium
i
4/30/2020OppenheimerBoost Price TargetOutperform$400.00 ➝ $425.00Medium
i
4/13/2020Morgan StanleyBoost Price TargetOverweight$343.00 ➝ $375.00Medium
i
3/29/2020BarclaysReiterated RatingBuyHigh
i
3/27/2020Morgan StanleyLower Price TargetOverweight$460.00 ➝ $343.00Medium
i
2/19/2020Royal Bank of CanadaReiterated RatingHold$370.00Low
i
2/18/2020Deutsche Bank AktiengesellschaftBoost Price TargetHold$363.00 ➝ $433.00Medium
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
2/14/2020MizuhoReiterated RatingBuy$405.00N/A
i
Rating by Ann Hynes at Mizuho
2/6/2020Morgan StanleyBoost Price TargetOverweight$457.00 ➝ $460.00Low
i
Rating by Ricky Goldwasser at Morgan Stanley
2/6/2020Deutsche Bank AktiengesellschaftBoost Price TargetBuy$319.00 ➝ $363.00Medium
i
Rating by George Hill at Deutsche Bank Aktiengesellschaft
2/6/2020MizuhoBoost Price TargetBuy$400.00 ➝ $405.00Medium
i
2/5/2020Cantor FitzgeraldBoost Price TargetOverweight$345.00 ➝ $400.00Low
i
Rating by S. Halper at Cantor Fitzgerald
1/27/2020Goldman Sachs GroupReiterated RatingBuy$425.00Medium
i
Rating by Stephen Tanal at Goldman Sachs Group Inc
1/23/2020UBS GroupBoost Price TargetNeutral$321.00 ➝ $406.00Low
i
1/8/2020Credit Suisse GroupBoost Price TargetOutperform$378.00 ➝ $400.00High
i
1/3/2020JPMorgan Chase & Co.Boost Price TargetOverweight$437.00 ➝ $448.00Medium
i
1/3/2020Goldman Sachs GroupReiterated RatingBuy ➝ Buy$425.00 ➝ $425.00Medium
i
12/20/2019JPMorgan Chase & Co.Boost Price TargetOverweight$322.00 ➝ $437.00Low
i
12/17/2019SunTrust BanksReiterated RatingHold$370.00Low
i
Rating by David S Macdonald at SunTrust Banks, Inc.
12/11/2019Wells Fargo & CompanyReiterated RatingOverweight$338.00 ➝ $400.00Low
i
12/6/2019BarclaysBoost Price TargetOverweight$327.00 ➝ $358.00Low
i
11/20/2019ArgusBoost Price TargetBuy$370.00Low
i
11/18/2019Morgan StanleyReiterated RatingBuy$337.00 ➝ $360.00Low
i
Rating by Ricky Goldwasser at Morgan Stanley
11/15/2019SunTrust BanksBoost Price TargetPositive ➝ Hold$350.00High
i
11/7/2019SunTrust BanksBoost Price TargetHold$335.00High
i
10/17/2019MizuhoInitiated CoverageBuy$316.00High
i
9/30/2019BMO Capital MarketsDowngradeOutperform ➝ Market Perform$345.00 ➝ $290.00Low
i
9/26/2019Morgan StanleyLower Price TargetOverweight$342.00 ➝ $337.00High
i
Rating by Ricky Goldwasser at Morgan Stanley
9/12/2019Deutsche Bank AktiengesellschaftInitiated CoverageHold$300.00High
i
8/23/2019Morgan StanleyBoost Price TargetOverweight$315.00 ➝ $342.00Medium
i
Rating by Ricky Goldwasser at Morgan Stanley
8/12/2019Cantor FitzgeraldUpgradeNeutral ➝ Overweight$300.00 ➝ $345.00Medium
i
Rating by S. Halper at Cantor Fitzgerald
8/1/2019JPMorgan Chase & Co.Boost Price TargetOverweight$288.00 ➝ $322.00Low
i
8/1/2019Piper Jaffray CompaniesBoost Price TargetOverweight$315.00 ➝ $341.00Low
i
8/1/2019UBS GroupBoost Price TargetNeutral$266.00 ➝ $317.00Low
i
Rating by Whit Mayo at UBS Group AG
8/1/2019SunTrust BanksBoost Price TargetHold$340.00Low
i
7/12/2019Morgan StanleyLower Price TargetOverweight$331.00 ➝ $315.00High
i
Rating by Zachary Sopcak at Morgan Stanley
5/2/2019SunTrust BanksLower Price Target$300.00Low
i
5/2/2019OppenheimerLower Price TargetOutperform$373.00 ➝ $350.00Low
i
5/2/2019Morgan StanleySet Price TargetBuy$331.00Low
i
Rating by Zachary Sopcak at Morgan Stanley
5/2/2019Credit Suisse GroupLower Price TargetOutperform$352.00 ➝ $315.00Low
i
5/2/2019CitigroupLower Price TargetBuy ➝ Buy$362.00 ➝ $302.00Low
i
4/23/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$266.00Medium
i
4/17/2019BarclaysLower Price TargetOverweight ➝ Overweight$351.00 ➝ $327.00Low
i
2/7/2019CitigroupLower Price TargetBuy ➝ Buy$397.00 ➝ $362.00Low
i
2/7/2019Credit Suisse GroupLower Price TargetOutperform$390.00 ➝ $352.00Low
i
1/14/2019StephensInitiated CoverageOverweight$336.00Low
i
1/11/2019CowenUpgradeMarket Perform ➝ Outperform$275.02High
i
1/6/2019BarclaysReiterated RatingBuy$351.00Low
i
1/2/2019Cantor FitzgeraldReiterated RatingHold$325.00High
i
12/20/2018JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$283.00Medium
i
11/8/2018Morgan StanleyBoost Price TargetOverweight ➝ Buy$400.00 ➝ $418.00Low
i
Rating by Zachary Sopcak at Morgan Stanley
11/8/2018BMO Capital MarketsSet Price TargetBuy$390.00Low
i
Rating by Matthew Borsch at BMO Capital Markets
11/8/2018Royal Bank of CanadaBoost Price TargetSector Perform ➝ Sector Perform$318.00 ➝ $349.00Low
i
11/8/2018Credit Suisse GroupBoost Price TargetOutperform ➝ Outperform$370.00 ➝ $390.00Low
i
11/8/2018Bank of AmericaBoost Price TargetBuy$400.00 ➝ $415.00Medium
i
11/8/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$388.00 ➝ $410.00High
i
9/19/2018SunTrust BanksBoost Price TargetHold$380.00Low
i
9/17/2018CowenInitiated CoverageMarket Perform$372.00Low
i
9/13/2018BarclaysInitiated CoverageOverweight ➝ Overweight$370.00Medium
i
9/4/2018Credit Suisse GroupBoost Price TargetOutperform$350.00 ➝ $370.00Low
i
9/4/2018ArgusBoost Price TargetBuy$375.00Low
i
8/24/2018Piper Jaffray CompaniesBoost Price TargetOverweight$355.00 ➝ $380.00Low
i
8/2/2018SunTrust BanksReiterated RatingHold$350.00Low
i
8/2/2018Piper Jaffray CompaniesReiterated RatingBuy$355.00Low
i
8/2/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$338.00 ➝ $375.00Low
i
8/2/2018Morgan StanleyBoost Price TargetOverweight ➝ Overweight$362.00 ➝ $365.00Low
i
8/2/2018Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$356.00 ➝ $372.00Low
i
8/2/2018Royal Bank of CanadaReiterated RatingHold$318.00Low
i
7/12/2018Morgan StanleyInitiated CoverageOverweight$362.00Low
i
7/6/2018Piper Jaffray CompaniesBoost Price TargetOverweight$326.00 ➝ $350.00Medium
i
6/25/2018BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$328.00 ➝ $355.00Low
i
6/1/2018CitigroupReiterated RatingBuy ➝ Buy$280.00 ➝ $340.00Low
i
5/3/2018OppenheimerBoost Price TargetOutperform$305.00 ➝ $311.00Low
i
4/23/2018Cantor FitzgeraldReiterated RatingHold$250.00High
i
4/16/2018ArgusBoost Price TargetBuy ➝ Buy$270.00 ➝ $330.00Low
i
4/4/2018Piper Jaffray CompaniesReiterated RatingBuy$313.00Low
i
2/12/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$253.00 ➝ $271.00Low
i
2/9/2018Deutsche Bank AktiengesellschaftBoost Price TargetHold ➝ Hold$259.00 ➝ $270.00Low
i
2/8/2018OppenheimerBoost Price TargetOutperform$275.00 ➝ $305.00Medium
i
2/8/2018SVB LeerinkBoost Price TargetOutperform ➝ Outperform$280.00 ➝ $300.00High
i
2/8/2018Credit Suisse GroupUpgradeNeutral ➝ Outperform$264.90 ➝ $246.00Medium
i
2/7/2018Cantor FitzgeraldReiterated RatingHold$250.00Medium
i
1/12/2018Jefferies Financial GroupUpgradeHold ➝ Buy$221.00Medium
i
1/3/2018Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$305.00Low
i
12/13/2017CowenReiterated RatingBuy$285.00Low
i
12/5/2017Cantor FitzgeraldReiterated RatingHold$230.00Low
i
Rating by S. Halper at Cantor Fitzgerald
11/10/2017Credit Suisse GroupLower Price TargetNeutral$256.00 ➝ $246.00N/A
i
11/10/2017BMO Capital MarketsBoost Price TargetOutperform$290.00 ➝ $300.00N/A
i
11/9/2017Morgan StanleyLower Price TargetOverweight$276.00 ➝ $270.00N/A
i
11/9/2017Royal Bank of CanadaReiterated RatingSector Perform ➝ Sector Perform$245.00 ➝ $242.00N/A
i
11/2/2017Credit Suisse GroupInitiated CoverageNeutral$256.00N/A
i
10/16/2017BMO Capital MarketsInitiated CoverageOutperform$300.00N/A
i
10/13/2017Jefferies Financial GroupReiterated RatingHold$257.00N/A
i
10/10/2017Royal Bank of CanadaReiterated RatingHold$245.00N/A
i
10/9/2017JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$253.00N/A
i
9/20/2017CowenReiterated RatingOutperform$230.00 ➝ $275.00Medium
i
8/17/2017Morgan StanleyBoost Price TargetOverweight$269.00 ➝ $276.00Low
i
8/9/2017UBS GroupReiterated RatingNeutral$237.00 ➝ $250.00Low
i
8/7/2017Deutsche Bank AktiengesellschaftBoost Price TargetHold$234.00 ➝ $243.00Low
i
8/4/2017Jefferies Financial GroupReiterated RatingHold$257.00Low
i
8/3/2017Cantor FitzgeraldReiterated RatingNeutral$200.00 ➝ $223.00Low
i
Rating by S. Halper at Cantor Fitzgerald
8/3/2017OppenheimerBoost Price TargetOutperform$236.00 ➝ $255.00Medium
i
8/3/2017Credit Suisse GroupReiterated RatingOutperform$250.00 ➝ $260.00High
i
8/3/2017Piper Jaffray CompaniesBoost Price TargetOverweight$280.00High
i
7/14/2017Piper Jaffray CompaniesReiterated RatingBuy$246.00Low
i
7/14/2017CowenReiterated RatingBuy$230.00Low
i
7/14/2017Bank of AmericaBoost Price TargetBuy$270.00 ➝ $275.00Low
i
7/13/2017Credit Suisse GroupReiterated RatingOutperform$245.00 ➝ $250.00Low
i
6/28/2017UBS GroupReiterated RatingNeutral$205.00 ➝ $237.00N/A
i
6/28/2017CitigroupInitiated CoverageBuy ➝ Buy$275.00Medium
i
6/23/2017Cantor FitzgeraldReiterated RatingNot Available ➝ NeutralLow
i
Rating by S. Halper at Cantor Fitzgerald
6/9/2017ArgusUpgradeHold ➝ Buy$260.00Low
i
6/6/2017Morgan StanleyInitiated CoverageOverweight ➝ Overweight$262.00Low
i
6/5/2017Royal Bank of CanadaReiterated RatingHold$214.00Low
i
5/30/2017SVB LeerinkBoost Price TargetOutperform$250.00 ➝ $265.00Low
i
5/10/2017Deutsche Bank AktiengesellschaftLower Price TargetHold$234.00 ➝ $216.00Low
i
5/4/2017Jefferies Financial GroupReiterated RatingHold$221.00 ➝ $230.00High
i
4/26/2017Cantor FitzgeraldBoost Price TargetNeutral$190.00 ➝ $200.00Low
i
Rating by J. France at Cantor Fitzgerald
4/25/2017Evercore ISIReiterated RatingOutperform$240.00Low
i
4/25/2017CowenReiterated RatingOutperform$230.00Low
i
4/21/2017Jefferies Financial GroupDowngradeBuy ➝ Hold$237.00 ➝ $221.00Low
i
4/5/2017Deutsche Bank AktiengesellschaftInitiated CoverageHold$216.00Low
i
3/30/2017CIBCReiterated RatingOutperformLow
i
3/30/2017OppenheimerInitiated CoverageOutperform ➝ Outperform$236.00 ➝ $236.00Low
i
3/24/2017Jefferies Financial GroupReiterated RatingBuy$237.00Medium
i
2/27/2017Evercore ISIReiterated RatingOverweightN/A
i
2/15/2017Cantor FitzgeraldBoost Price TargetNeutral$186.00 ➝ $190.00N/A
i
Rating by J. France at Cantor Fitzgerald
2/10/2017Royal Bank of CanadaReiterated RatingHold$207.00N/A
i
2/6/2017Cantor FitzgeraldInitiated CoverageNeutral$186.00N/A
i
Rating by J. France at Cantor Fitzgerald
1/27/2017Bank of AmericaInitiated CoverageBuyN/A
i
1/24/2017Stifel NicolausDowngradeBuy ➝ Hold$214.00 ➝ $210.00N/A
i
1/18/2017ArgusReiterated RatingHoldN/A
i
1/9/2017BarclaysReiterated RatingHold$217.00N/A
i
1/6/2017Cantor FitzgeraldReiterated RatingHold$225.00N/A
i
Rating by J. France at Cantor Fitzgerald
1/3/2017Piper Jaffray CompaniesInitiated CoverageOverweight$231.00N/A
i
12/16/2016Jefferies Financial GroupReiterated RatingBuy$237.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
12/7/2016Cantor FitzgeraldDowngradeBuy ➝ Hold$225.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
12/4/2016140166Reiterated RatingNeutral$180.00 ➝ $200.00N/A
i
12/1/2016Jefferies Financial GroupReiterated RatingBuy$206.00 ➝ $230.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
11/14/2016UBS GroupSet Price TargetHold$194.00N/A
i
Rating by A.J. Rice at UBS Group AG
11/11/2016Credit Suisse GroupUpgradeNeutral ➝ Outperform$175.00 ➝ $210.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
11/10/2016JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$163.00 ➝ $202.00N/A
i
Rating by Gary Taylor at JPMorgan Chase & Co.
11/8/2016UBS GroupReiterated RatingNeutral$171.00 ➝ $170.00N/A
i
Rating by a.j. rice at UBS Group AG
11/7/2016BarclaysReiterated RatingHold$191.00N/A
i
11/7/2016Jefferies Financial GroupReiterated RatingBuy$206.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
10/14/2016BarclaysReiterated RatingEqual Weight$191.00N/A
i
10/13/2016140166Reiterated RatingNeutral$180.00N/A
i
10/13/2016Royal Bank of CanadaLower Price TargetSector Perform$222.00 ➝ $217.00N/A
i
9/22/2016Evercore ISIInitiated CoverageBuy$200.00N/A
i
9/13/2016Credit Suisse GroupReiterated RatingHold$188.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
8/31/2016UBS GroupReiterated RatingHoldN/A
i
Rating by A.J. Rice at UBS Group AG
8/23/2016ArgusReiterated RatingHoldN/A
i
8/22/2016UBS GroupReiterated RatingHoldN/A
i
Rating by A.J. Rice at UBS Group AG
8/16/2016Credit Suisse GroupBoost Price TargetNeutral$175.00 ➝ $188.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
8/8/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Joseph France at Cantor Fitzgerald
8/4/2016Jefferies Financial GroupLower Price TargetBuy$220.00 ➝ $217.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
8/4/2016BarclaysLower Price TargetEqual Weight$193.00 ➝ $191.00N/A
i
7/25/2016Jefferies Financial GroupReiterated RatingBuy$210.00 ➝ $220.00N/A
i
Rating by David Windley at Jefferies Financial Group Inc.
7/22/2016Royal Bank of CanadaReiterated RatingBuy$220.00 ➝ $224.00N/A
i
7/22/2016Royal Bank of CanadaBoost Price TargetOutperform$220.00 ➝ $224.00N/A
i
7/22/2016FBR & CoLower Price TargetMkt Perform$220.00 ➝ $170.00N/A
i
7/21/2016Credit Suisse GroupBoost Price TargetNeutral$160.00 ➝ $170.00N/A
i
Rating by Scott Fidel at Credit Suisse Group AG
7/21/2016Wolfe ResearchUpgradeOutperform$192.00N/A
i
7/18/2016Jefferies Financial GroupUpgradeHold ➝ Buy$158.89 ➝ $210.00N/A
i
7/9/2016Cantor FitzgeraldReiterated RatingBuyN/A
i
Rating by Joseph France at Cantor Fitzgerald
7/8/2016JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$196.00 ➝ $150.00N/A
i
6/28/2016Credit Suisse GroupReiterated RatingHoldN/A
i
Rating by Scott Fidel at Credit Suisse Group AG
6/28/2016Wolfe ResearchInitiated CoverageMarket Perform$244.00N/A
i
6/21/2016SVB LeerinkReiterated RatingOutperformN/A
i
Rating by Ana Gupte at SVB Leerink LLC
6/7/2016UBS GroupReiterated RatingHold$181.00 ➝ $199.00N/A
i
Rating by A.J. Rice at UBS Group AG
5/22/2016Morgan StanleyReiterated RatingHoldN/A
i
Rating by Andrew Schenker at Morgan Stanley
5/19/2016SVB LeerinkReiterated RatingBuy$230.00N/A
i
5/5/2016Credit Suisse GroupReiterated RatingHoldN/A
i
Rating by Scott Fidel at Credit Suisse Group AG
5/5/2016Royal Bank of CanadaBoost Price TargetSector Perform$209.00 ➝ $220.00N/A
i
5/5/2016Stifel NicolausBoost Price TargetBuy$209.00 ➝ $220.00N/A
i
4/5/2016SVB LeerinkReiterated RatingOutperformN/A
i
Rating by Ana Gupte at SVB Leerink LLC
4/5/2016CowenReiterated RatingOutperformN/A
i
2/16/2016JPMorgan Chase & Co.Lower Price TargetOverweight$201.00 ➝ $196.00N/A
i
Rating by Justin Lake at JPMorgan Chase & Co.
2/14/2016FBR & CoReiterated RatingMarket Perform$208.00N/A
i
2/11/2016Cantor FitzgeraldReiterated RatingBuy$230.00N/A
i
Rating by Joseph France at Cantor Fitzgerald
2/5/2016SVB LeerinkReiterated RatingOutperform$230.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
1/15/2016140166Lower Price Target$197.00 ➝ $180.00N/A
i
12/16/2015Credit Suisse GroupInitiated CoverageNeutral$185.00N/A
i
11/9/2015SVB LeerinkReiterated RatingBuy$230.00N/A
i
Rating by Ana Gupte at SVB Leerink LLC
11/9/2015Royal Bank of CanadaLower Price TargetSector Perform$223.00 ➝ $215.00N/A
i
(Data available from 10/24/2015 forward)
Humana logo
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; financial protection products; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE South Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2019, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Read More

Today's Range

Now: $444.31
$441.74
$449.43

50 Day Range

MA: $413.01
$385.42
$441.16

52 Week Range

Now: $444.31
$208.25
$449.43

Volume

480,009 shs

Average Volume

1,047,044 shs

Market Capitalization

$58.78 billion

P/E Ratio

16.90

Dividend Yield

0.57%

Beta

0.88